251
|
Munisamy M, Ndoh K, Abdelbadee A, Espejo I, Manjuh F, Tamas A, Salako O, Roitberg F. Adapting Cancer Civil Society Organizations to Accelerate COVID-19 Vaccinations in People Living With Cancer in Low- and Middle-Income Countries-A Commentary. JCO Glob Oncol 2021; 7:1194-1198. [PMID: 34292779 PMCID: PMC8457777 DOI: 10.1200/go.21.00195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Murallitharan Munisamy
- National Cancer Society of Malaysia, Kuala Lumpur, Malaysia.,Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland
| | - Kingsley Ndoh
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,Department of Global Health, University of Washington, Seattle, WA
| | - Ahmed Abdelbadee
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt
| | - Isthar Espejo
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,Fundacion Aladina, Madrid, Spain
| | - Florence Manjuh
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,Women's Health Program, Cameroon Baptist Convention Health Services, Cameroon
| | - Alexandra Tamas
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,European Network for Smoking and Tobacco Prevention
| | - Omolola Salako
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,Department of Radiation Biology, Radiotherapy and Radiodiagnosis, College of Medicine, University of Lagos, Nigeria.,Sebeccly Cancer Care, Lagos, Nigeria.,Oncopadi Digital Clinic, Lagos, Nigeria
| | - Felipe Roitberg
- Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.,Instituto do Câncer do Estado de São Paulo, Sao Paulo, Brazil.,European Society for Medical Oncology (ESMO), Lugano, Switzerland
| |
Collapse
|
252
|
Cheli S, Lam WWT, Estapé T, Winterling J, Bahcivan O, Andritsch E, Weis J, Centeno I, Serpentini S, Farkas C, Wengström Y, Fioretto L, Baider L, Lam CCL, Goldzweig G. Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients. Psychooncology 2021; 31:46-53. [PMID: 34314560 PMCID: PMC8420575 DOI: 10.1002/pon.5775] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Revised: 07/06/2021] [Accepted: 07/22/2021] [Indexed: 12/13/2022]
Abstract
Objective To explore the role of personality traits in moderating the relation between COVID‐19 risk perception and treatment adherence, and between risk perception and psychosocial distress in patients diagnosed with cancer. Methods An online survey (n = 1281) was conducted worldwide in seven countries (Austria, Germany, Hong Kong, Italy, Spain, Sweden, and Turkey). Inclusion criteria were to be 18 years of age or older, have received a cancer diagnosis, and be in treatment or follow‐up. A few moderated regression models were performed with both personality traits and Hierarchical Taxonomy of Psychopathology super‐spectra as moderators. Results Detachment, negative affectivity, psychoticism and all the super‐spectra significantly moderated the relation between coronavirus risk perception and psychosocial distress, after the adjusting effect of confidence in safeguards. Only negative affectivity moderated the association between coronavirus risk perception and treatment adherence. Conclusions Personality traits may foster the understanding of how a patient might adjust to cancer treatment and, more generically, to highly stressful events such as the COVID‐19 pandemic. Further research is needed to confirm the results in different cancer stages and types.
Collapse
Affiliation(s)
- Simone Cheli
- School of Human Health Sciences, University of Florence, Florence, Italy.,Center for Psychology and Health, Tages Charity, Florence, Italy
| | - Wendy W T Lam
- Faculty of Medicine, School of Public Health, Jockey Club Institute of Cancer Care, The University of Hong Kong, Hong Kong, China
| | | | - Jeanette Winterling
- Comprehensive Cancer Centre, Karolinska University Hospital, Stockholm, Sweden.,Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden
| | - Ozan Bahcivan
- OZ Psychology Family Counselling Centre, Izmir, Turkey
| | | | - Joachim Weis
- Medical Faculty Comprehensive Cancer Center, University Clinic Centre, Freiburg, Germany
| | - Isabel Centeno
- Fundación Elisabeth Kübler-Ross, San Pedro Garza García, Mexico
| | | | | | - Yvonne Wengström
- Comprehensive Cancer Centre, Karolinska University Hospital, Stockholm, Sweden.,Department of Neurobiology, Care Sciences and Society, Division of Nursing, Karolinska Institutet, Stockholm, Sweden
| | - Luisa Fioretto
- Dipartimento Oncologico, USL Toscana Centro, Florence, Italy
| | - Lea Baider
- Assuta Medical Center, Oncology Institute, Tel-Aviv, Israel
| | - Cherry C L Lam
- Faculty of Medicine, School of Public Health, Jockey Club Institute of Cancer Care, The University of Hong Kong, Hong Kong, China
| | - Gil Goldzweig
- The Academic College of Tel Aviv-Yaffo, Tel-Aviv, Israel
| |
Collapse
|
253
|
Tarricone R, Listorti E, Tozzi V, Torbica A, Banks H, Ghislandi S, Altini M, Annicchiarico M, Ardizzoni A, Bordon P, Bossi P, Cascinu S, Numico G, Puglisi F, Fasola G. Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy. J Cancer Policy 2021; 29:100297. [PMID: 34316437 PMCID: PMC8297965 DOI: 10.1016/j.jcpo.2021.100297] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 06/27/2021] [Accepted: 07/11/2021] [Indexed: 10/25/2022]
Abstract
Policymakers everywhere struggle to introduce therapeutic innovation while controlling costs, a particular challenge for the universal Italian National Healthcare System (SSN), which spends only 8.8% of GDP to care for one of the world's oldest populations. Oncology provides a telling example, where innovation has dramatically improved care and survival, transforming cancer into a chronic condition. However, innovation has also increased therapy duration, adverse event management, and service demand. The SSN risks collapse unless centralized cancer planning changes gear, particularly with Covid-19 causing treatment delays, worsening patient prognosis and straining capacity. In view of the 750 billion Euro "Next Generation EU", released by the European Union to relieve Member States hit by the pandemic, the SSN tapped a multidisciplinary research team to identify key strategies for equitable uptake of innovations in treatment and delivery, with emphasis on data-driven technological and managerial advancements - and lessons from Covid-19.
Collapse
Affiliation(s)
- R Tarricone
- Department of Social and Political Science, Bocconi University, Via Roentgen 1, 20135, Milan, Italy.,Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Via Sarfatti 10, 20136, Milan, Italy
| | - E Listorti
- Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Via Sarfatti 10, 20136, Milan, Italy
| | - V Tozzi
- Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Via Sarfatti 10, 20136, Milan, Italy
| | - A Torbica
- Department of Social and Political Science, Bocconi University, Via Roentgen 1, 20135, Milan, Italy.,Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Via Sarfatti 10, 20136, Milan, Italy
| | - H Banks
- Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Via Sarfatti 10, 20136, Milan, Italy
| | - S Ghislandi
- Department of Social and Political Science, Bocconi University, Via Roentgen 1, 20135, Milan, Italy
| | - M Altini
- Istituto Romagnolo per lo studio dei Tumori "Dino Amadori", 47014, Meldola, Italy
| | | | | | | | - P Bossi
- University of Brescia, Brescia, Italy
| | - S Cascinu
- Vita-San Raffaele University, Milan, Italy
| | - G Numico
- Azienda Ospedaliera Santa Croce di Cuneo, Italy
| | - F Puglisi
- Centro di Riferimento Oncologico, Aviano, Italy
| | - G Fasola
- Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy
| |
Collapse
|
254
|
Boughey JC, Snyder RA, Kantor O, Zheng L, Chawla A, Nguyen TT, Hillman SL, Hahn OM, Mandrekar SJ, Roland CL. Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Ann Surg Oncol 2021; 28:7311-7316. [PMID: 34236550 PMCID: PMC8265286 DOI: 10.1245/s10434-021-10406-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Accepted: 06/24/2021] [Indexed: 12/20/2022]
Abstract
The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to medical facilities impacted clinical trial participation. Clinical trial accrual dropped at the onset of the pandemic, with improvement over time. Adjustments were made to some trial protocols, allowing telephone or video-enabled consent. Certain study activities were permitted to be performed by local healthcare providers or at local laboratories to maximize patients' ability to continue on study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials and changes at the local, cooperative group, and national level.
Collapse
Affiliation(s)
| | - Rebecca A Snyder
- Division of Surgical Oncology, East Carolina University Brody School of Medicine, Greenville, NC, USA
| | - Olga Kantor
- Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA
| | - Linda Zheng
- American College of Surgeons Cancer Research Program, Chicago, IL, USA
| | - Akhil Chawla
- Division of Surgical Oncology, Department of Surgery, Northwestern Medicine Regional Medical Group, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | | | - Shauna L Hillman
- Department of Health Sciences Research, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA
| | - Olwen M Hahn
- Alliance Protocol Operations Office, University of Chicago, Chicago, IL, USA
| | - Sumithra J Mandrekar
- Department of Health Sciences Research, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA
| | - Christina L Roland
- Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| |
Collapse
|
255
|
Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. J Clin Med 2021; 10:jcm10132945. [PMID: 34209085 PMCID: PMC8269002 DOI: 10.3390/jcm10132945] [Citation(s) in RCA: 84] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 06/26/2021] [Accepted: 06/27/2021] [Indexed: 12/29/2022] Open
Abstract
Background: The long-term effects of COVID-19 remain largely unclear. This study aims to investigate post-acute health consequences and mortality one year after hospital discharge. Methods: All surviving adult patients who were discharged after hospital admission due to acute COVID-19 in the first wave of the pandemic underwent a comprehensive interview. Functional assessment was performed in patients aged over 65. Clinical and hospital records were reviewed and mortality causes assessed. Results: A total of 587 patients with COVID-19 were discharged from hospital, including 266 after hospital admission and 321 from the emergency room. Mortality within the following year occurred in 34/266 (12.8%) and 10/321 (3.1%), respectively, due to causes directly or possibly related to COVID-19 in 20.5% and 25% of patients. Post-COVID-19 syndrome was assessed in 543 patients at one year from discharge. Any clinical complaint was reported by 90.1% of patients who needed hospitalization and 80.4% of those discharged from the emergency room (p = 0.002), with breathlessness (41.6%), tiredness (35.4%), ageusia (30.2%), and anosmia (26.3%) being the most common complaints. Ongoing symptoms attributed to COVID-19 were reported by 66.8% and 49.5% of patients, respectively (p < 0.001). Newly developed COPD, asthma, diabetes, heart failure, and arthritis—as well as worsening of preexisting comorbidities—were found. Conclusions: One-year mortality among survivors of acute COVID-19 was 7.5%. A significant proportion of COVID-19 patients experienced ongoing symptoms at 1 year from onset of the disease.
Collapse
|
256
|
Lambert G, Drummond K, Tahasildar B, Carli F. Virtual Prehabilitation in Surgical Cancer Patients During the Covid-19 Pandemic: A Prospective Feasibility Study (Preprint). JMIR Res Protoc 2021; 11:e29936. [PMID: 35522464 PMCID: PMC9123533 DOI: 10.2196/29936] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 12/24/2021] [Accepted: 03/21/2022] [Indexed: 11/23/2022] Open
Abstract
Background Since the beginning of the COVID-19 pandemic, preoperative care, also termed prehabilitation, has become increasingly relevant due to the decreasing functional and psychosocial health of patients with cancer, which is a result of the pandemic restrictions. Concurrently, access to telehealth has improved; telehealth comprises all remote care delivery facilitated by information technologies (ie, virtually). Objective The aim of this protocol is to describe the rationale and methodology for a major trial investigating the feasibility and safety of multimodal virtual prehabilitation services (ie, teleprehabilitation). Methods This single-arm feasibility trial aims to recruit 100 patients with cancer to receive teleprehabilitation throughout their preoperative period. The inclusion criteria are as follows: (1) 18 years of age or older, (2) scheduled for elective cancer surgery and referred by a surgeon, (3) medically cleared by the referring physician to engage in physical activity, and (4) have a good comprehension of the English or French language. Feasibility will be assessed by documenting recruitment, adherence, and retention rates, in addition to patients’ motives for not participating in the trial, low participation, or discontinuation. The secondary outcome of safety will be assessed by reporting program-related adverse events. Results The Montreal General Hospital Foundation funded the project in August 2020. The protocol was then approved by the Research Ethics Board of the McGill University Health Centre in January 2021 (ID No. 2021-6730). The first patient was recruited in March 2021, and recruitment is expected to end in September 2022. As of March 2022, 36 patients have been recruited, including 24 who have completed their participation. No adverse events have been reported. Data collection is expected to conclude in November 2022. Data analysis will be performed, and the results will be published by the beginning of 2023. Conclusions This trial will provide guidance on the use of telehealth in the administration of prehabilitation services. The trial will provide a large amount of information that will respond to gaps in the literature, as there are minimal reports on the use of telehealth rehabilitation and prehabilitation services among elderly populations and in acute contexts, such as the preoperative period. Trial Registration ClinicalTrials.gov NCT0479956; https://clinicaltrials.gov/ct2/show/NCT04799561 International Registered Report Identifier (IRRID) DERR1-10.2196/29936
Collapse
Affiliation(s)
- Genevieve Lambert
- Department of Experimental Surgery, Faculty of Medicine, McGill University, Montreal, QC, Canada
- Peri Operative Program, Department of Anesthesia, McGill University Health Center, Montreal, QC, Canada
| | - Kenneth Drummond
- Department of Experimental Surgery, Faculty of Medicine, McGill University, Montreal, QC, Canada
- Peri Operative Program, Department of Anesthesia, McGill University Health Center, Montreal, QC, Canada
| | - Bhagya Tahasildar
- Peri Operative Program, Department of Anesthesia, McGill University Health Center, Montreal, QC, Canada
| | - Francesco Carli
- Department of Experimental Surgery, Faculty of Medicine, McGill University, Montreal, QC, Canada
- Peri Operative Program, Department of Anesthesia, McGill University Health Center, Montreal, QC, Canada
| |
Collapse
|